NICE (NCSYF) director Dvir Yocheved lists stock options and share holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
NICE Ltd. director Dvir Yocheved has reported current equity holdings in a Form 3 insider filing. The disclosure lists multiple stock option awards over NICE ordinary shares with exercise prices ranging from 0.2929 to 232.2005 and expiration dates between 2026 and 2031. The filing also shows direct ownership of 395 NICE ordinary shares. Footnotes explain that some options are already fully vested and exercisable, while others will vest in installments through specific dates in 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
14 transactions reported
Mixed
14 txns
Insider
Dvir Yocheved
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Options — 3,980 shares (Direct);
Ordinary Shares — 395 shares (Direct)
Footnotes (1)
- The stock option is fully vested and currently exercisable. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026. The stock option will vest on September 30, 2026.
FAQ
What does the NICE (NCSYF) Form 3 for Dvir Yocheved disclose?
The Form 3 shows director Dvir Yocheved holding multiple stock options and 395 NICE ordinary shares. The options cover NICE ordinary shares at various exercise prices and expiration dates, providing a detailed view of her existing equity-based compensation and ownership in the company.
What types of securities does Dvir Yocheved hold in NICE Ltd.?
Dvir Yocheved directly holds Ordinary Shares of NICE and several awards of Options over NICE ordinary shares. The options have distinct exercise prices and expiration dates, forming a portfolio of equity incentives aligned with NICE’s long-term performance.
What are key terms of Dvir Yocheved’s NICE stock options?
The options relate to NICE ordinary shares with exercise prices starting at 0.2929 and extending above 200, and expiration dates spanning from 2026 through 2031. These terms define when and at what price she may acquire NICE shares via the options.
What do the footnotes in Dvir Yocheved’s NICE Form 3 explain?
Footnotes clarify the vesting status of certain stock options. One footnote states an option is fully vested and currently exercisable, while others explain options that vest in installments or fully by specific dates in 2026, detailing when those options become exercisable.
Does the NICE Form 3 show any recent insider buying or selling by Dvir Yocheved?
The data presented reflect holdings, not new purchases or sales, with transactions labeled as holdings and transaction codes described as unknown. It functions as an initial ownership snapshot rather than a record of recent buy or sell activity.